Results for T-Cell Acute Lymphoblastic Leukemia

1 - 10 of 50

Dr. Tan studies transcriptional regulation during normal development and disease. This involves the interplay of multiple transcription and epigenetic factors in a 3D chromosomal environment. Using experimental genomics and computational modeling, Dr. Tan investigates transcriptional regulatory networks underlying embryonic hematopoiesis, T cell differentiation, and pediatric leukemia.

E-mail:

tank1 [at] chop.edu

Sarah K. Tasian, MD

Dr. Tasian's research centers on the bench-to-bedside investigation of precision medicine therapies for high-risk childhood leukemias.

E-mail:

tasians [at] chop.edu

CART38, a Novel Therapy for T-ALL: Q&A With David Teachey, MD, and Caroline Diorio, MD

Published on

Jan 19, 2023

in Cornerstone Blog

Seed Grant Funds Research for CART38, a Novel Therapy for T-ALL

In this Q&A, Drs. Teachey and Diorio discuss their partnership and research of a novel CAR T-cell therapy for one of the most common pediatric cancers.

In The News: MIS-C, Antibody Treatment for Eosinophilic Esophagitis, ASH 2022

Published on

Jan 6, 2023

in Cornerstone Blog

Our Scientists’ Research Highlighted In the News

See highlights of work by Children’s Hospital of Philadelphia researchers that is leading to novel findings.

Science Stands Out in Our Most Engaging Cornerstone Stories of 2022

Published on

Dec 29, 2022

in Cornerstone Blog

Science Stands Out in Our Most Engaging Cornerstone Stories of 2022

These six Cornerstone stories garnered the most engagements from our CHOP Research Twitter, Facebook, and LinkedIn channels.

In the News: Outstanding Science Award, Highly Cited Researcher, STAT Wunderkinds

Published on

Dec 9, 2022

in Cornerstone Blog

This week's news roundup features an outstanding science award, Highly Cited Researchers, and STAT Wunderkinds, along with new research about cancer risk with birth defects, epilepsy, and acute myeloid leukemia.